Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absorb, acid, advent, air, alpha, analyzed, anticorruption, assay, assimilation, atezolizumab, Avelumab, basiliximab, BDL, beneficiary, biomedical, biosmilar, bribed, bribing, Brink, CARgenix, CBC, cetuximab, Corrupt, crucial, CTC, Cytolumina, deal, deconsolidating, deduction, Deferral, disgorgement, drag, durvalumab, EGFR, elusive, EMD, entrance, envision, epithelial, Erbitux, excellent, exit, expedite, extinguished, FCPA, Fetolumina, flow, forty, founder, FTC, Globavir, glyclosylation, glycosylation, groundbreaking, hand, HBV, hereof, hierarchy, HIF, Hope, IgE, ImmuneOncia, immunogenicity, infliximab, investee, Japanese, Jaymin, Jeffrey, judged, lawfully, length, lieu, lowest, Mabtech, magnitude, moiety, mutant, mutated, NADA, Nam, NanoVelcro, NantBioScience, NantCancerStemCell, NantCell, nantibody, NantKwest, NantPharma, NantStem, neuralgia, Ng, noncontrolling, noncurrent, nonprofit, notification, ofof, omalizumab, oncoprotein, Oxley, passed, Patel, pattern, pembrolizumab, penetrate, penetrating, penetration, perpetual, pharmacy, placental, Plant, pose, presumption, purity, Remicade, remote, representation, resubstitution, retrospectively, revalued, revolutionize, rich, risky, Scintilla, shrinkage, simplify, Simulect, siRNA, straight, Subtopic, therewith, thing, TNF, TNK, transparent, unadjusted, unchanged, unconditional, undisclosed, undruggable, unmodified, unobservable, uptake, virtue, wrote, Xolair, yearso, Youn, Yuhan
Removed:
Abraxane, aforementioned, aggregating, applying, arrive, assigned, AU, bid, breast, clinically, composed, confirmation, Cornerstone, Ct, David, diblock, dosing, EIP, encompassing, Garden, Germany, half, interacting, Korean, malignant, MBC, metastatic, micellar, nanoparticle, NSCLC, oncologic, optionee, paragraph, preceding, precision, pro, radiation, recommended, removal, repurchase, repurchased, retail, role, subjective, Suite, Suntree, surgery, translate, translation, unutilized, utilization, vincent, widely, women
Filing tables
Filing exhibits
SRNE similar filings
Filing view
External links
Exhibit 21
Subsidiaries of Registrant
|
| State of Jurisdiction of Organization |
| Percentage of Voting Securities Owned |
| |
Concortis Biosystems, Corp. |
| Delaware |
|
| 100 | % |
Sorrento Therapeutics, Inc. Hong Kong Limited |
| Hong Kong, China |
|
| 100 | % |
Ark Animal Health, Inc. |
| Delaware |
|
| 100 | % |
TNK Therapeutics, Inc. |
| Delaware |
|
| 99 | % |
LA Cell, Inc. |
| Delaware |
|
| 64 | % |
Sorrento Biologics, Inc. |
| Delaware |
|
| 99 | % |
Scintilla Pharmaceuticals, Inc. |
| Delaware |
|
| 99 | % |